Expression of macrophage markers in cryoglobulinemic glomerulonephritis a - possible role of CXCL9

被引:5
|
作者
Kowalewska, J. [1 ]
Okon, K. [2 ]
Szynaka, B. [3 ]
Naumnik, B. [4 ,5 ]
机构
[1] Med Univ Bialystok, Dept Med Pathomorphol, PL-15269 Bialystok, Poland
[2] Jagiellonian Univ, Coll Med, Dept Pathomorphol, Krakow, Poland
[3] Med Univ Bialystok, Dept Histol, PL-15269 Bialystok, Poland
[4] Med Univ Bialystok, Dept Nephrol, PL-15269 Bialystok, Poland
[5] Med Univ Bialystok, Transplantat Dialysis Unit, PL-15269 Bialystok, Poland
来源
ADVANCES IN MEDICAL SCIENCES | 2013年 / 58卷 / 02期
关键词
Cryoglobulinemia; cryoglobulinemic glomerulonephritis; macrophages; CXCL9; HEPATITIS-C VIRUS; LYMPHOPOIETIN TRANSGENIC MICE; RENAL-ALLOGRAFT REJECTION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; CHEMOKINE RECEPTORS; INFECTION; KIDNEY; DISEASE; TRANSPLANTATION; MECHANISMS;
D O I
10.2478/ams-2013-0030
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: Cryoglobulinemic glomerulonephritis (CGGN) is a type of membranoproliferative glomerulonephritis (MPGN) that develops in patients with systemic cryoglobulinemia. To date the exact pathogenesis of CGGN remains unclear. It has been suggested that macrophages may be significant contributors to the glomerular injury in this disease. In our study we attempt to characterize the macrophages in human CGGN using classical activation and regulatory macrophage markers. Material and Method: We searched our database for renal biopsy cases of CGGN. Macrophages were detected using a monoclonal anti-CD68 antibody. Two groups of macrophage markers were used: classical activation markers, including iNOS, CXCL9 and CCL20, and regulatory markers: SPHK1 and LIGHT. The stains were performed using immunohistochemical method. Results: Five patients with CGGN were identified. Four patients had systemic cryoglobulinemia and two had a serological evidence of hepatitis C virus infection. In all cases the glomeruli contained numerous macrophages. Staining for activatory macrophage markers revealed a strong nuclear staining for CXCL9 in numerous cells, including those corresponding to the macrophage location. Staining for the other activatory markers, as well as staining for regulatory markers, was not significant. Conclusion: In this study of human CGGN we showed a striking expression of cytokine CXCL9, a classical macrophage activation marker, by the macrophages and possibly other cell types within the glomeruli. This observation points to the possible role of classically activated macrophages in the pathogenesis of MPGN. If this observation is confirmed on a larger group of patients, the cytokine CXCL9 could become a potential therapeutic target for human CGGN.
引用
收藏
页码:394 / 400
页数:7
相关论文
共 50 条
  • [1] Prognostic role of endogenous CXCL9 expression in intrahepatic cholangiocarcinoma
    Fukuda, Yasunari
    Asaoka, Tadafumi
    Eguchi, Hidetoshi
    Iwagami, Yoshifumi
    Akita, Hirofumi
    Noda, Takehiro
    Gotoh, Kunihito
    Kobayashi, Shogo
    Doki, Yuichiro
    Mori, Masaki
    CANCER SCIENCE, 2018, 109 : 1337 - 1337
  • [2] The Role Of Cxcl9 And Monocytes In Sarcoidosis
    Sun, S. A.
    Ho, M.
    Ramstein, J.
    Su, R.
    Garudadri, S.
    Bhakta, N. R.
    Koth, L. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [3] The Role Of Cxcl9 And Monocytes In Sarcoidosis
    Benn, B. S.
    Sun, S. A.
    Ho, M. E.
    Ramstein, J.
    Su, R.
    Garudadri, S.
    Bhakta, N. R.
    Koth, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [4] THE ROLE OF CXCL9 AND CXCL10 IN SEPTIC SHOCK
    Sherwood, E.
    Guo, Y.
    Fang, G.
    Herzig, D. S.
    SHOCK, 2012, 37 : 100 - 100
  • [5] The Role of CXCL13 and CXCL9 in Early Breast Cancer
    Razis, Evangelia
    Kalogeras, Konstantine T.
    Kotsantis, Ioannis
    Koliou, Georgia-Angeliki
    Manousou, Kyriaki
    Wirtz, Ralph
    Veltrup, Elke
    Patsea, Helen
    Poulakaki, Nikiforita
    Dionysopoulos, Dimitrios
    Pervana, Stavroula
    Gogas, Helen
    Koutras, Angelos
    Pentheroudakis, George
    Christodoulou, Christos
    Linardou, Helena
    Pavlakis, Kitty
    Koletsa, Triantafyllia
    Pectasides, Dimitrios
    Zagouri, Flora
    Fountzilas, George
    CLINICAL BREAST CANCER, 2020, 20 (01) : E36 - E53
  • [6] The expression of CXCL9 is elevated in congenital pulmonary hypertension
    Wang, Li
    Wang, Guo Liang
    Meng, Liu Kun
    Liu, Xiao Yan
    Liu, Sheng Hua
    Wei, Ying Jie
    CARDIOLOGY, 2013, 126 : 62 - 62
  • [7] The role of MIG/CXCL9 in cardiac allograft vasculopathy
    Yun, JJ
    Fischbein, MP
    Whiting, D
    Irie, Y
    Fishbein, MC
    Burdick, MD
    Belperio, J
    Strieter, RM
    Laks, H
    Berliner, JA
    Ardehali, A
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04): : 1307 - 1313
  • [8] CXCL9 does not ameliorate murine macrophage activation syndrome hepatitis
    Diamond, Tamir
    Lau, Michelle
    Morrissette, Jeremy
    Chu, Niansheng
    Behrens, Edward
    JOURNAL OF HEPATOLOGY, 2023, 78 : S450 - S451
  • [9] CXCL9: evidence and contradictions for its role in tumor progression
    Ding, Qiang
    Lu, Panpan
    Xia, Yujia
    Ding, Shuping
    Fan, Yuhui
    Li, Xin
    Han, Ping
    Liu, Jingmei
    Tian, Dean
    Liu, Mei
    CANCER MEDICINE, 2016, 5 (11): : 3246 - 3259
  • [10] CXCL13 and CXCL9 as diagnostic and therapy monitoring markers in central nervous system lymphoma
    Masouris, I.
    Pfirnnann, M.
    Manz, K.
    Koedeli, U.
    Von Baumgarten, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 392 - 392